B-Cell Level May Affect COVID Booster Efficacy in MS ...Middle East

Medscape - News
A B-cell count of at least 40/µL is necessary to mount an adequate antibody response to COVID-19 boosters in patients with multiple sclerosis, new research shows. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( B-Cell Level May Affect COVID Booster Efficacy in MS )

Apple Storegoogle play

Also on site :